FDA backs Vytorin after finishing study review
Thursday, January 8, 2009 - 16:21
in Health & Medicine
(AP) -- The Food and Drug Administration says patients should not stop taking Vytorin or other cholesterol-lowering drugs, based on its review of a controversial study.